These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 25549238)
1. Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. Qu C; Chen T; Fan C; Zhan Q; Wang Y; Lu J; Lu LL; Ni Z; Huang F; Yao H; Zhu J; Fan J; Zhu Y; Wu Z; Liu G; Gao W; Zang M; Wang D; Dai M; Hsia CC; Zhang Y; Sun Z PLoS Med; 2014 Dec; 11(12):e1001774. PubMed ID: 25549238 [TBL] [Abstract][Full Text] [Related]
2. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China]. Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608 [No Abstract] [Full Text] [Related]
3. [A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China]. Chen JG; Lu JH; Zhu YR; Zhu J; Zhang YH Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):721-6. PubMed ID: 21162830 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccination in children: the Taiwan experience. Ni YH; Chen DS Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181 [TBL] [Abstract][Full Text] [Related]
5. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination. Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197 [TBL] [Abstract][Full Text] [Related]
6. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan. Sun HY; Cheng CY; Lee NY; Yang CJ; Liang SH; Tsai MS; Ko WC; Liu WC; Wu PY; Wu CH; Lin HH; Hung CC PLoS One; 2014; 9(2):e90194. PubMed ID: 24587275 [TBL] [Abstract][Full Text] [Related]
8. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China]. Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135 [TBL] [Abstract][Full Text] [Related]
9. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China. Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735 [TBL] [Abstract][Full Text] [Related]
10. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400 [TBL] [Abstract][Full Text] [Related]
11. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322 [TBL] [Abstract][Full Text] [Related]
12. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative. Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491 [TBL] [Abstract][Full Text] [Related]
13. Minimization of hepatitis B infection by a 25-year universal vaccination program. Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China. Wang WL; Shu ZJ; Zhou LX; Zhao YR Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774 [TBL] [Abstract][Full Text] [Related]
16. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Luo Z; Li L; Ruan B Int J Infect Dis; 2012 Feb; 16(2):e82-8. PubMed ID: 22178658 [TBL] [Abstract][Full Text] [Related]
17. To "B" or not to "B": efficacy of a neonatal hepatitis B vaccination program to prevent primary liver cancer and end-stage liver disease. Karnik R; Singal AG Gastroenterology; 2015 May; 148(5):1073-5. PubMed ID: 25824352 [No Abstract] [Full Text] [Related]
18. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008 [TBL] [Abstract][Full Text] [Related]
19. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Yu SY; Zhu YJ; Li WG Biol Trace Elem Res; 1997 Jan; 56(1):117-24. PubMed ID: 9152515 [TBL] [Abstract][Full Text] [Related]
20. Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer. Chen T; Qian G; Fan C; Sun Y; Wang J; Lu P; Xue X; Wu Y; Zhang Q; Jin Y; Wu Y; Gan Y; Lu J; Kensler TW; Groopman JD; Tu H Hepatoma Res; 2018; 4():. PubMed ID: 29479565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]